Evidence map›Paper›PMID 32299284›Full record

Trial reportJournal of the American Heart Association2020

Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs.

Jacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, Christopher P Cannon, Timothy D Henry, Gregg C Fonarow, Niteesh K Choudhry, Eileen Fonseca, Narinder Bhalla, James M Eudicone and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Jacob A DollVA Puget Sound Health Care System Seattle WA.
Lisa A KaltenbachDuke Clinical Research Institute Durham NC.
Kevin J AnstromDuke Clinical Research Institute Durham NC.
Christopher P CannonBrigham and Women's Hospital Boston MA.
Timothy D HenryThe Carl and Edyth Lindner Center for Research and Education at The Christ Hospital Cincinnati OH.
Gregg C FonarowUniversity of California-Los Angeles CA.
Niteesh K ChoudhryCenter for Healthcare Delivery Sciences Brigham and Women's Hospital and Harvard Medical School Boston MA.
Eileen FonsecaAstraZeneca Wilmington DE.
Narinder BhallaAstraZeneca Wilmington DE.
James M EudiconeAstraZeneca Wilmington DE.
Eric D PetersonDuke University Durham NC.
Tracy Y WangDuke University Durham NC.
AstraZeneca (United States) · USBrigham and Women's Hospital · USClinical Research Institute · USDuke University · USCedars-Sinai Medical Center · USUniversity of California, Los Angeles · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Hospitals commonly provide a short-term supply of free P2Y

Indexed as

Drug CostsHealth ExpendituresMedication AdherenceAgedCost-Benefit AnalysisDeductibles and CoinsuranceFemaleHumansMaleMiddle AgedMyocardial InfarctionPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsQuality ImprovementQuality Indicators, Health CareTime FactorsPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonistsmedication adherencemyocardial infarctionquality improvement

Identifiers

PMID32299284
PMCPMC7428537
OpenAlexW3016633861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.